{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:22:15Z","timestamp":1782602535613,"version":"3.54.5"},"reference-count":38,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2014,10,6]]},"abstract":"<jats:p>A 67-year-old woman with a history of hypertension and type 2 diabetes mellitus was admitted to the hospital due to aphasia and left-sided hemiparesis during the past 5\u2005h with resolution of symptoms within 24\u2005h. On admission laboratory analysis showed haemoglobin 19.2\u2005g\/dL and haematocrit 55.1%. Cerebral CT scan was also performed on admission revealing periventricular leucoaraiosis. Studies to investigate the cause of erythrocytosis were started and elevated erythropoietin levels were found. In order to investigate a secondary cause of erythrocytosis an abdominal ultrasound was conducted revealing a left renal mass. CT scans of thorax, abdomen and pelvis confirmed renal mass 8\u00d78\u2005cm of diameter, suggestive of neoplasm without associated lymphadenopathy or metastases. Radical nephrectomy was performed and a pathological diagnosis demonstrated clear cell renal cell carcinoma and was staged as T2aN0M0.<\/jats:p>","DOI":"10.1136\/bcr-2013-202572","type":"journal-article","created":{"date-parts":[[2014,10,21]],"date-time":"2014-10-21T10:19:11Z","timestamp":1413886751000},"page":"bcr2013202572","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Transient ischaemic attack secondary to paraneoplastic erythrocytosis"],"prefix":"10.1136","volume":"2014","author":[{"given":"Aldo Ren\u00e9","family":"Hurtarte Sandoval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan Josu\u00e9","family":"Flores Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Francis","family":"Andrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Alejandro Yaxcal","family":"Chon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,10,21]]},"reference":[{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.1","unstructured":"Kasper DL , Braunwald E , Fauci AS , et al . Harrison's principles of internal medicine. 16th edn. McGraw-Hill, 2005."},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1017\/S109285290001021X","article-title":"Hypercoagulable states and stroke: a selective review","volume":"10","author":"Levine","year":"2005","journal-title":"CNS Spectr"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood.V75.3.577.577","article-title":"Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia","volume":"75","author":"Da Silva","year":"1990","journal-title":"Blood"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.4","unstructured":"GLOBOCAN [online database]. 2009. http:\/\/www-dep.iarc.fr\/ (accesed 1 Nov 2009)."},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.5","first-page":"5231","article-title":"Smoking and renal carcinoma","volume":"50","author":"La Vecchia","year":"1990","journal-title":"Cancer Res"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/77.2.351"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20618"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197909133011107"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.9","doi-asserted-by":"publisher","DOI":"10.1126\/science.7112106"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.10","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(87)90059-8"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.11","doi-asserted-by":"publisher","DOI":"10.1038\/327721a0"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2009.02467.x"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.13","unstructured":"Tefferi A . Diagnostic approach to the patient with polycythemia. UpToDate, June 2013."},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.14","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19960611)66:6<723::AID-IJC2>3.0.CO;2-1"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.15","unstructured":"Garnick M . Primary neoplasms of the kidney. In: Brady H , Wilcox C, eds. Therapy in nephrology and hypertension: a companion to Brenner and Rector's the kidney. Philadelphia: Saunders, 1999."},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.16","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2010.175"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.17","first-page":"197","article-title":"Pheochromocytoma and secondary erythrocytosis: role of tumour erythropoietin secretion","volume":"37","author":"Dr\u00e9nou","year":"1995","journal-title":"Nouv Rev Fr Hematol"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.18","first-page":"249","article-title":"Ultrastructural pathology of human renal cell tumors","volume":"6","author":"Tannenbaum","year":"1971","journal-title":"Pathol Annu"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.19","unstructured":"Bengi\u00f3 R , Pautasso O , Kerkebe R , et al . Urolog\u00eda razonada, para Estudiantes y M\u00e9dicos Generales. Segunda edici\u00f3n. Rosario, Argentina: Editorial CORPUS, 2004."},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.20","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000135837.64840.55"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0302-2838(03)00216-1"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.22","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1971)28:5<1165::AID-CNCR2820280513>3.0.CO;2-G"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.23","unstructured":"Atkins MB . Clinical manifestations, evaluation and staging of renal cell carcinoma. UpToDate, May 2013."},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.24","first-page":"216","article-title":"Paraneoplastic manifestations of renal cell carcinoma","volume":"14","author":"Gold","year":"1996","journal-title":"Semin Urol Oncol"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.25","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(77)90001-2"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.26","first-page":"161","article-title":"Reversible hepatic dysfunction associated with hypernephroma","volume":"45","author":"Utz","year":"1970","journal-title":"Mayo Clin Proc"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1993.tb16285.x"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-040030"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.29","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90747-1"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.30","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410170133013"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64453-9"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.32","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.1880030408"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.33","unstructured":"McDougal WS , Garnick M . Clinical signs and symptoms of kidney cancer. In: Vogelzang NJ , Scardino PT , Shipley WU , et al ., eds. Comprehensive textbook of genitourinary oncology. Baltimore: Williams & Wilkins, 1996."},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(86)80001-2"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.35","doi-asserted-by":"publisher","DOI":"10.1007\/BF00184870"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.36","first-page":"1167","article-title":"Supervivencia en relaci\u00f3n a los factores pron\u00f3sticos en una serie de pacientes con carcinoma de c\u00e9lulas renales","volume":"60","author":"Gim\u00e9nez-Bach","year":"2007","journal-title":"Arch Esp Urol"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.37","doi-asserted-by":"crossref","unstructured":"Delacroix SE , Wood CG , Jonasch E . Renal neoplasia. In: Taal MW , Chertow GM , Marsden PA , et al ., eds. Brenner and Rector's the kidney. 9th edn. Philadelphia, PA: Saunders, An Imprint of Elsevier, 2011:1508\u201335.","DOI":"10.1016\/B978-1-4160-6193-9.10040-5"},{"key":"2025042706473317000_2014.oct21_1.bcr2013202572.38","unstructured":"Atkins MB . Anti-angiogenic and molecularly targeted therapy for advanced renal cell carcinoma. UpToDate, June 2013."}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-202572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T13:47:40Z","timestamp":1745761660000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-202572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,21]]},"references-count":38,"alternative-id":["10.1136\/bcr-2013-202572"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-202572","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,21]]}}}